A detailed history of Mcf Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mcf Advisors LLC holds 755 shares of NVO stock, worth $65,964. This represents 0.01% of its overall portfolio holdings.

Number of Shares
755
Previous 755 -0.0%
Holding current value
$65,964
Previous $107,000 16.82%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$122.71 - $146.91 $6,135 - $7,345
-50 Reduced 6.21%
755 $107,000
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $33,594 - $44,717
329 Added 69.12%
805 $103,000
Q4 2023

Feb 01, 2024

BUY
$87.78 - $105.45 $41,081 - $49,350
468 Added 5850.0%
476 $49,000
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $727 - $1,596
8 New
8 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.